Plant-Derived Recombinant Vaccines against Zoonotic Viruses

22Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

Abstract

Emerging and re-emerging zoonotic diseases cause serious illness with billions of cases, and millions of deaths. The most effective way to restrict the spread of zoonotic viruses among humans and animals and prevent disease is vaccination. Recombinant proteins produced in plants offer an alternative approach for the development of safe, effective, inexpensive candidate vaccines. Current strategies are focused on the production of highly immunogenic structural proteins, which mimic the organizations of the native virion but lack the viral genetic material. These include chimeric viral peptides, subunit virus proteins, and virus-like particles (VLPs). The latter, with their ability to self-assemble and thus resemble the form of virus particles, are gaining traction among plant-based candidate vaccines against many infectious diseases. In this review, we summarized the main zoonotic diseases and followed the progress in using plant expression systems for the production of recombinant proteins and VLPs used in the development of plant-based vaccines against zoonotic viruses.

Cite

CITATION STYLE

APA

Zahmanova, G., Takova, K., Valkova, R., Toneva, V., Minkov, I., Andonov, A., & Lukov, G. L. (2022, February 1). Plant-Derived Recombinant Vaccines against Zoonotic Viruses. Life. MDPI. https://doi.org/10.3390/life12020156

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free